Page last updated: 2024-08-23

paclitaxel and Cardiometabolic Syndrome

paclitaxel has been researched along with Cardiometabolic Syndrome in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ahn, Y; Bae, JH; Chae, IH; Chae, JK; Chae, SC; Cho, JG; Cho, MC; Choi, D; Chung, WS; Hong, TJ; Hur, SH; Jang, YS; Jeong, MH; Kang, JC; Kim, CJ; Kim, YJ; Lee, MG; Park, JC; Park, SJ; Rha, SW; Rhew, JY; Seong, IW; Seung, KB; Yoon, J	1

Trials

1 trial(s) available for paclitaxel and Cardiometabolic Syndrome

Article	Year
Comparison of paclitaxel-, sirolimus-, and zotarolimus-eluting stents in patients with acute ST-segment elevation myocardial infarction and metabolic syndrome. Circulation journal : official journal of the Japanese Circulation Society, 2011, Volume: 75, Issue:9 Topics: Antineoplastic Agents, Phytogenic; Asian People; Disease-Free Survival; Drug-Eluting Stents; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Metabolic Syndrome; Middle Aged; Myocardial Infarction; Paclitaxel; Republic of Korea; Sirolimus; Survival Rate	2011

Article

Year

Comparison of paclitaxel-, sirolimus-, and zotarolimus-eluting stents in patients with acute ST-segment elevation myocardial infarction and metabolic syndrome.

Circulation journal : official journal of the Japanese Circulation Society, 2011, Volume: 75, Issue:9

Topics: Antineoplastic Agents, Phytogenic; Asian People; Disease-Free Survival; Drug-Eluting Stents; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Metabolic Syndrome; Middle Aged; Myocardial Infarction; Paclitaxel; Republic of Korea; Sirolimus; Survival Rate

2011